Skip to main content

Cartesian Therapeutics, Inc.

RNAC
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001453687

No open-market purchases or sales by Cartesian Therapeutics, Inc. insiders were filed in the last 90 days; 94 institutions reported holding it in 13F filings for Q2 2026, worth $90.4M in total; no superinvestor holds it.

Q2 2026 vs. Q1 2026

How the institutions holding Cartesian Therapeutics, Inc. changed between Q1 2026 and Q2 2026.

All holders in Q2 2026All holders in Q1 2026

13F holders of RNAC: Q1 2026 compared with Q2 2026
MeasureQ1 2026Of which not filed for Q2 2026Q2 2026Change
Holders83194+12
Shares7.15M4.64K8.68M+1.54M (+21.5%)
Value$43.9M$28.5K$90.4M+$46.5M (+105.8%)

1 institution that held it in Q1 2026 haven't filed for Q2 2026 yet. Not filing isn't selling, so the changes leave them out.

New holders (24)

Institutions that held Cartesian Therapeutics, Inc. at the end of Q2 2026 but not at the end of Q1 2026.

Institutions new to RNAC in Q2 2026
InstitutionSharesValue% of portfolio
Jupiter Topco LLC200,905$2.09M0.00%
ADAR1 Capital Management, LLC98,877$1.03M0.05%
Diadema Partners LP87,057$907.1K0.32%
Bank of America Corp84,624$881.8K0.00%
Walleye Capital LLC81,828$852.6K0.00%
Jump Financial, LLC66,800$696.1K0.01%
CM Management, LLC60,000$625.2K0.40%
Point72 Asset Management, L.P.43,627$454.6K0.00%
Trexquant Investment LP41,046$427.7K0.00%
D. E. Shaw & Co., Inc.28,651$298.5K0.00%
Fedenia Advisers LLC28,509$297.1K0.07%
Ieq Capital, LLC25,416$264.8K0.00%
Persistent Asset Partners Ltd22,191$231.2K0.07%
Invesco Ltd.20,687$215.6K0.00%
Brevan Howard Capital Management LP19,365$201.8K0.00%
Cerity Partners LLC16,848$175.6K0.00%
Mariner, LLC14,813$154.3K0.00%
Jane Street Group, LLC11,824$123.2K0.00%
Price T Rowe Associates Inc10,758$113.0K0.00%
Nisa Investment Advisors, LLC1,600$16.7K0.00%
North Star Investment Management Corp.1,084$11.3K0.00%
Quarry LP15$1560.00%
Clearstead Advisors, LLC9$940.00%
JPL Wealth Management, LLC4$420.00%

Sold out (12)

Institutions that held Cartesian Therapeutics, Inc. at the end of Q1 2026 and filed for Q2 2026 without it.

Not filed for Q2 2026 yet (1)

Institutions that held Cartesian Therapeutics, Inc. at the end of Q1 2026 and haven't filed a 13F for Q2 2026. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding RNAC in Q1 2026 that haven't filed for Q2 2026
InstitutionShares, Q1 2026Value, Q1 2026
CWM, LLC4,636$28.5K